Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: A new world of angiogenesis research

American Journal of Pathology

Volumn 158, Issue 3, 2001, Pages 789-796

  Brat, D J ^a   Van Meir, E G ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ANGIOGENESIS; APOPTOSIS; ASTROCYTOMA; BLOOD VESSEL PERMEABILITY; CANCER; CANCER GRADING; CELL DEATH; CELL PROLIFERATION; EXPERIMENTAL MODEL; GENE OVEREXPRESSION; GENETIC MANIPULATION; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; MICROVASCULARIZATION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NOTE; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 0035108298     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64025-4     Document Type: Note

References (54)

1. Angiogenesis in cancer and other diseases
2. Vascular-specific growth factors and blood vessel formation
3. Tumor Angiogenesis: Therapeutic implications
4. Tumor angiogenesis: Past, present and the near future
5. VPF/VEGF and the angiogenic response
6. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
7. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
8. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
9. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
10. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
11. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery
12. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor
13. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
14. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis
15. Vascular permeability factor, an endothelial cell mitogen related to PDGF
16. Molecular and biological properties of the vascular endothelial growth factor family of proteins
17. Vascular endothelial growth factors VEGF-B and VEGF-C
18. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Fit4)
19. Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature
20. Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189
21. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
22. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4
23. Roles of ephrinB ligands and EphB receptors in cardiovascular development: Demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis
24. The biology of vascular endothelial growth factor
25. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies
26. Different angiogenic pathways characterize superficial and invasive bladder cancer
27. Modulation of neoangiogenesis in bronchial preneoplastic lesions
28. Angiogenesis in the neoplastic sequence of Barrett's oesophagus. Correlation with VEGF expression
29. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
30. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
31. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
32. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
33. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
34. Distinct roles of the receptor tyrosine kinases Tie1 and Tie2 in blood vessel formation
35. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
36. Tumors of the central nervous system
37. Glioblastoma
38. Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: An immuno-light and immuno-electron microscopic study
39. Glomeruloid vascular structures in glioblastoma multiforme: An immunohistochemical and ultrastructural study
40. Tumor induction of VEGF promoter activity in stromal cells
41. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma
42. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies
43. Cytokines and tumors of the central nervous system
44. Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma
45. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis
46. Mechanisms of angiogenesis in the brain
47. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
48. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms
49. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
50. Suppression of tumor growth through disruption of hypoxia-inducible transcription
51. Hypoxia, HIF-1, and the pathophysiology of common human diseases
52. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients
53. Vascular apoptosis and involution in gliomas precede neovascularization: A novel concept for glioma growth and angiogenesis
54. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis